Q2 2025 Earnings Call Transcript August 7, 2025 AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.12, ...

Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Welcome to the Lisata Therapeutics Second Quarter 2025 Financial ...

This collection encompasses studies exploring the role of gut microbiota, omics analyses, and biomarkers in various disease ...

Rowan University and Sentrimed, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced results from a National Cancer Institute (NCI) ...

Significant regulatory advances for lead candidate EB613 streamline Phase 3 clinical development and reduce regulatory hurdles. These 10 stocks could mint the next wave of millionaires › Entera Bio ...

Key Points GAAP earnings per share of $(1.99) for Q2 2025 missed analyst estimates by $0.07. Net loss attributable to common stockholders (GAAP) narrowed to $5.7 million for Q2 2025, down from $7.4 ...